Clinical Trial Update: Sipuleucel-T in Metastatic Castrate Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of sipuleucel-T in metastatic castration-resistant prostate cancer was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• sipuleucel-T (sipuleucel-T)

Snippet

Sponsor: Dendreon | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-06-05